Advisory Panelist Conflicts Of Interest Have Weak Favorable Effect On Votes
Executive Summary
FDA advisory committee members with conflicts of interest are more likely to vote favorably for the drug being discussed than those without conflicts, a study conducted by Public Citizen's Health Research Group found
You may also be interested in...
FDA Gains No Impartiality Benefit From Conflict-Of-Interest Policy, Advocates Say
Friends of Cancer Research cites an FDA-sponsored study to argue that agency adherence to an advisory committee conflict-of-interest policy that is stricter than required by law does not increase the impartiality of panel members’ recommendations.
FDA Gains No Impartiality Benefit From Conflict-Of-Interest Policy, Advocates Say
Friends of Cancer Research cites an FDA-sponsored study to argue that agency adherence to an advisory committee conflict-of-interest policy that is stricter than required by law does not increase the impartiality of panel members’ recommendations.
Advisory Cmte. Conflict of Interest Waivers Common; Avandia Is High Water Mark
As currently convened, the majority of FDA advisory committee meetings on drugs would likely violate a limit on participation by experts with a financial conflict of interest being considered by Congress